Regulation of hemolysin expression and virulence of staphylococcus aureus by a serine/threonine kinase and phosphatase

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Burnside, Kellie ^a   Lembo, Annalisa ^a   de los Reyes, Melissa ^a   Iliuk, Anton ^b   BinhTran, Nguyen Thao ^a   Connelly, James E ^a   Lin, Wan Jung ^a   Schmidt, Byron Z ^a   Richardson, Anthony R ^c   Fang, Ferric C ^c   Tao, Weiguo Andy ^b   Rajagopal, Lakshmi ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BACTERIAL ENZYME; DNA BINDING HISTONE LIKE PROTEIN; GUANOSINE PHOSPHATE; INTERLEUKIN 6; PHOSPHOPEPTIDE; SERINE ASPARTE RICH FIBRINOGEN BONE SIALOPROTEIN BINDING PROTEIN; SERINE THREONINE KINASE 1; SERINE THREONINE PHOSPHATASE 1; THREONINE; UNCLASSIFIED DRUG; HEMOLYSIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INFLAMMATION; KIDNEY ABSCESS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TRANSPOSON; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; HEMOLYSIS; MASS SPECTROMETRY; METABOLISM; MUTATION; PATHOGENICITY; VIRULENCE;

MUS; STAPHYLOCOCCUS AUREUS;

GENE EXPRESSION PROFILING; HEMOLYSIN PROTEINS; HEMOLYSIS; MASS SPECTROMETRY; MUTATION; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN-SERINE-THREONINE KINASES; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 77956199888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011071     Document Type: Article

References (97)

1. Berner R (2004) Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period. Expert Rev Anti Infect Ther 2: 427-437.
2. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, et al. (1999) The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infectious Diseases 5: 9-17.
3. Styers D, Sheehan DJ, Hogan P, Sahm DF (2006) Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5: 2.
4. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases 7: 178-182.
5. Lowy FD (1998) Staphylococcus aureus infections. New England Journal of Medicine 339: 520-532.
6. DeLeo FR, Diep BA, Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infectious Disease Clinics of North America 23: 17-34.
7. Otto M. Looking toward basic science for potential drug discovery targets against community-associated MRSA. Medicinal Research Reviews 30: 1-22.
8. Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infection and Immunity 75: 1040-1044.
9. Kielian T, Cheung A, Hickey WF (2001) Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infection and Immunity 69: 6902-6911.
10. Hume EB, Dajcs JJ, Moreau JM, O'Callaghan RJ (2000) Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infection and Immunity 68: 6052-6055.
11. Nilsson IM, Hartford O, Foster T, Tarkowski A (1999) Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infection and Immunity 67: 1045-1049.
12. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ (1994) Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infection and Immunity 62: 2478-2482.
13. Patel AH, Nowlan P, Weavers ED, Foster T (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infection and Immunity 55: 3103-3110.
14. Bhakdi S, Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. Microbiological Reviews 55: 733-751.
15. Husmann M, Beckmann E, Boller K, Kloft N, Tenzer S, et al. (2009) Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis. FEBS Letters 583: 337-344.
16. Bhakdi S, Muhly M, Korom S, Hugo F (1989) Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infection and Immunity 57: 3512-3519.
17. Dragneva Y, Anuradha CD, Valeva A, Hoffmann A, Bhakdi S, et al. (2001) Subcytocidal attack by staphylococcal alpha-toxin activates NF-kappaB and induces interleukin-8 production. Infection and Immunity 69: 2630-2635.
18. Onogawa T (2002) Staphylococcal alpha-toxin synergistically enhances inflammation caused by bacterial components. FEMS Immunology and Medical Microbiology 33: 15-21.
19. Bartlett AH, Foster TJ, Hayashida A, Park PW (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. Journal of Infectious Diseases 198: 1529-1535.
20. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, et al. (2009) NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proceedings of the National Academy of Sciences of the United States of America 106: 12873-12878.
21. Bubeck Wardenburg J, Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. Journal of Experimental Medicine 205: 287-294.
22. DeLeo FR, Otto M (2008) An antidote for Staphylococcus aureus pneumonia? Journal of Experimental Medicine 205: 271-274.
23. Ragle BE, Bubeck Wardenburg J (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infection and Immunity 77: 2712-2718.
24. Glenny AT, Stevens NF (1935) Staphylococcal toxins and antitoxins. The Journal of Pathology and Bacteriology 40: 201-210.
25. Projan SJ, Kornblum J, Kreiswirth B, Moghazeh SL, Eisner W, et al. (1989) Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res 17: 3305.
26. Huseby M, Shi K, Brown CK, Digre J, Mengistu F, et al. (2007) Structure and biological activities of beta toxin from Staphylococcus aureus. Journal of Bacteriology 189: 8719-8726.
27. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews 13: 16-34.
28. O'Callaghan RJ, Callegan MC, Moreau JM, Green LC, Foster TJ, et al. (1997) Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infection and Immunity 65: 1571-1578.
29. Hayashida A, Bartlett AH, Foster TJ, Park PW (2009) Staphylococcus aureus beta-toxin induces lung injury through syndecan-1. American Journal of Pathology 174: 509-518.
30. Kim CS, Jeon SY, Min YG, Rhyoo C, Kim JW, et al. (2000) Effects of beta-toxin of Staphylococcus aureus on ciliary activity of nasal epithelial cells. Laryngoscope 110: 2085-2088.
31. Sibbald MJ, Ziebandt AK, Engelmann S, Hecker M, de Jong A, et al. (2006) Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiology and Molecular Biology Reviews 70: 755-788.
32. Buist G, Ridder AN, Kok J, Kuipers OP (2006) Different subcellular locations of secretome components of Gram-positive bacteria. Microbiology 152: 2867-2874.
33. Kim J, Kendall DA (2000) Sec-dependent protein export and the involvement of the molecular chaperone SecB. Cell Stress and Chaperones 5: 267-275.
34. Wiseman GM (1975) The hemolysins of Staphylococcus aureus. Bacteriological Reviews 39: 317-344.
35. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P (1988) Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. Journal of Bacteriology 170: 4365-4372.
36. Bhakoo M, Birkbeck TH, Freer JH (1982) Interaction of Staphylococcus aureus delta-lysin with phospholipid monolayers. Biochemistry 21: 6879-6883.
37. Freer JH, Birkbeck TH (1982) Possible conformation of delta-lysin, a membrane-damaging peptide of Staphylococcus aureus. Journal of Theoretical Biology 94: 535-540.
38. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, et al. (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO Journal 12: 3967-3975.
39. Vandenesch F, Kornblum J, Novick RP (1991) A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. Journal of Bacteriology 173: 6313-6320.
40. Hoch J, Silhavy T, editors. (1995) Two-component Signal Transduction. Washington DC: American Society for Microbiology.
41. Kreikemeyer B, McIver KS, Podbielski A (2003) Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends in Microbiology 11: 224-232.
42. Rajagopal L (2009) Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiology 4: 201-221.
43. Raggiaschi R, Gotta S, Terstappen GC (2005) Phosphoproteome analysis. Bioscience Reports 25: 33-44.
44. Krishna RG, Wold F (1998) Posttranslational Modifications. In: Angeletti RH, editor. Protein Analysis and Design. San Diego: Academic Press. pp. 121-206.
45. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Molecular Microbiology 48: 1429-1449.
46. Yarwood JM, Schlievert PM (2003) Quorum sensing in Staphylococcus infections. Journal of Clinical Investigation 112: 1620-1625.
47. Giraudo AT, Calzolari A, Cataldi AA, Bogni C, Nagel R (1999) The sae locus of Staphylococcus aureus encodes a two-component regulatory system. FEMS Microbiology Letters 177: 15-22.
48. Giraudo AT, Cheung AL, Nagel R (1997) The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Archives of Microbiology 168: 53-58.
49. Giraudo AT, Mansilla C, Chan A, Raspanti C, Nagel R (2003) Studies on the expression of regulatory locus sae in Staphylococcus aureus. Current Microbiology 46: 246-250.
50. Fournier B, Klier A, Rapoport G (2001) The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Molecular Microbiology 41: 247-261.
51. Manna AC, Cheung AL (2003) sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infection and Immunity 71: 343-353.
52. Schmidt KA, Manna AC, Gill S, Cheung AL (2001) SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infection and Immunity 69: 4749-4758.
53. McNamara PJ, Bayer AS (2005) A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis. Infection and Immunity 73: 3806-3809.
54. Said-Salim B, Dunman PM, McAleese FM, Macapagal D, Murphy E, et al. (2003) Global regulation of Staphylococcus aureus genes by Rot. Journal of Bacteriology 185: 610-619.
55. McNamara PJ, Milligan-Monroe KC, Khalili S, Proctor RA (2000) Identification, cloning, and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus. Journal of Bacteriology 182: 3197-3203.
56. Traber K, Novick R (2006) A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate delta- and alpha-haemolysins. Molecular Microbiology 59: 1519-1530.
57. Seidl K, Stucki M, Ruegg M, Goerke C, Wolz C, et al. (2006) Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrobial Agents and Chemotherapy 50: 1183-1194.
58. Wolfe AJ (2005) The acetate switch. Microbiology and Molecular Biology Reviews 69: 12-50.
59. Bernheimer AW, Avigad LS, Kim KS (1974) Staphylococcal sphingomyelinase (beta-hemolysin). Annals of the New York Academy of Sciences 236: 292-306.
60. Lin WJ, Walthers D, Connelly JE, Burnside K, Jewell KA, et al. (2009) Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR. Molecular Microbiology 71: 1477-1495.
61. Rajagopal L, Vo A, Silvestroni A, Rubens CE (2006) Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Molecular Microbiology 62: 941-957.
62. Novick RP (1991) Genetic systems in staphylococci. Methods in Enzymology 204: 587-636.
63. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. Journal of Bacteriology 190: 300-310.
64. Chaffin DO, Rubens CE (1998) Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene 219: 91-99.
65. Okada N, Geist RT, Caparon MG (1993) Positive transcriptional control of mry regulates virulence in the group A streptococcus. Molecular Microbiology 7: 893-903.
66. Adhikari RP, Arvidson S, Novick RP (2007) A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan. Infection and Immunity 75: 4534-4540.
67. Richardson AR, Dunman PM, Fang FC (2006) The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Molecular Microbiology 61: 927-939.
68. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
69. Richardson AR, Libby SJ, Fang FC (2008) A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319: 1672-1676.
70. Silvestroni A, Jewell KA, Lin WJ, Connelly JE, Ivancic MM, et al. (2009) Identification of serine/threonine kinase substrates in the human pathogen group B streptococcus. J Proteome Res 8: 2563-2574.
71. Beltramini AM, Mukhopadhyay CD, Pancholi V (2009) Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infection and Immunity 77: 1406-1416.
72. Donat S, Streker K, Schirmeister T, Rakette S, Stehle T, et al. (2009) Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. Journal of Bacteriology 191: 4056-4069.
73. Rajagopal L, Vo A, Silvestroni A, Rubens CE (2005) Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Molecular Microbiology 56: 1329-1346.
74. Benton BM, Zhang JP, Bond S, Pope C, Christian T, et al. (2004) Large-scale identification of genes required for full virulence of Staphylococcus aureus. Journal of Bacteriology 186: 8478-8489.
75. Bae T, Banger AK, Wallace A, Glass EM, Aslund F, et al. (2004) Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proceedings of the National Academy of Sciences of the United States of America 101: 12312-12317.
76. Begun J, Sifri CD, Goldman S, Calderwood SB, Ausubel FM (2005) Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model. Infection and Immunity 73: 872-877.
77. Mei JM, Nourbakhsh F, Ford CW, Holden DW (1997) Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Molecular Microbiology 26: 399-407.
78. Peterson CL, Laniel MA (2004) Histones and histone modifications. Current Biology 14: R546-551.
79. Cerutti H, Casas-Mollano JA (2009) Histone H3 phosphorylation: universal code or lineage specific dialects? Epigenetics 4: 71-75.
80. Oberto J, Nabti S, Jooste V, Mignot H, Rouviere-Yaniv J (2009) The HU regulon is composed of genes responding to anaerobiosis, acid stress, high osmolarity and SOS induction. PLoS ONE 4: e4367.
81. Yao J, Zhong J, Fang Y, Geisinger E, Novick RP, et al. (2006) Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. RNA 12: 1271-1281.
82. Josefsson E, McCrea KW, Ni Eidhin D, O'Connell D, Cox J, et al. (1998) Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology 144 (Pt 12): 3387-3395.
83. Sabat A, Melles DC, Martirosian G, Grundmann H, van Belkum A, et al. (2006) Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. Journal of Clinical Microbiology 44: 1135-1138.
84. Stranger-Jones YK, Bae T, Schneewind O (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 103: 16942-16947.
85. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, et al. (2002) Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Molecular Microbiology 44: 1033-1044.
86. Debarbouille M, Dramsi S, Dussurget O, Nahori MA, Vaganay E, et al. (2009) Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. Journal of Bacteriology 191: 4070-4081.
87. Schafer D, Lam TT, Geiger T, Mainiero M, Engelmann S, et al. (2009) A point mutation in the sensor histidine kinase SaeS of Staphylococcus aureus strain Newman alters the response to biocide exposure. Journal of Bacteriology 191: 7306-7314.
88. Herbert S, Ziebandt AK, Ohlsen K, Schafer T, Hecker M, et al. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infection and Immunity.
89. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, et al. (2008) Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319: 962-965.
90. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nature Medicine 13: 1405-1406.
91. Horton RM (1995) PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Molecular Biotechnology 3: 93-99.
92. Chaffin DO, Beres SB, Yim HH, Rubens CE (2000) The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol 182: 4466-4477.
93. Jeng A, Sakota V, Li Z, Datta V, Beall B, et al. (2003) Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. Journal of Bacteriology 185: 1208-1217.
94. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, et al. (1997) Current Protocols in Molecular Biology. Janssen K, editor. New York: John Wiley & Sons, Inc.
95. Altemeier WA, Zhu X, Berrington WR, Harlan JM, Liles WC (2007) Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway. Journal of Leukocyte Biology 82: 721-728.
96. Iliuk A, Tao WA (2009) Quantitative phospho-proteomics based on soluble nanopolymers. Methods in Molecular Biology 527: 117-129, ix.
97. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, et al. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB Journal 23: 3393-3404.